Maybe ��now that he's bought a company that can convince consumers to shell out $100 for a pair of ear buds.
Apple's acquisition of Beats Electronics gives the technology giant a small but much-needed product refresh in both hardware and software.
In addition to its line of hip consumer electronics ��Beats sells audio gear at Best Buy's online store for between $80 and $380, for example ��the Santa Monica-based upstart rolled out an online streaming music service in January.
Given that global streaming music revenue surged 51 percent in 2013, while U.S. sales of downloaded singles fell 3.3 percent, the deal should goose Apple's iTunes business, where growth has slowed dramatically in the past 12 months.
Top 5 Consumer Service Stocks To Watch For 2015: Spectrum Pharmaceuticals Inc.(SPPI)
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company, primarily focuses on oncology and hematology. The company engages in acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. It markets Zevalin, a prescribed form of cancer therapy, radioimmunotherapy; and Fusilev, a novel folate analog formulation and the pharmacologically active isomer of the racemic compound, calcium leucovorin. The company?s drugs in late stage development include Apaziquone, an anti-cancer agent; and Belinostat, a histone deacytelase inhibitor. Its drugs in development also include Ozarelix a luteinizing hormone releasing hormone antagonist, which is in Phase II clinical stage; SPI-1620, a peptide agonist of endothelin B receptors, which is in Phase I clinical stage; and RenaZorb, a lanthanum-based nanoparticle phosphate binding agent, which is in preclinical stage. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is based in Henderson, Nevada.
Advisors' Opinion:- [By James E. Brumley]
Eight months ago, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) was a train wreck. Shares had plunged from $12.43 to $7.79 on the heels of bad news, and SPPI wouldn't stop bleeding until it hit a low of $6.92 a few days after the big selloff. That bad news? A warning that its full-year sales (and particularly sales of its cancer drug Fusilev) would be well short of expectations.
- [By Jake L'Ecuyer]
Spectrum Pharmaceuticals (NASDAQ: SPPI) shares tumbled 9.77 percent to $8.18 after the company announced an offering of $100 million of convertible notes.
- [By Rich Smith]
Spectrum Pharmaceuticals (NASDAQ: SPPI ) has found itself a new Executive Vice President, a new Chief Financial Officer, and a new Principal Accounting�Officer. They're all the same person.
Best Up And Coming Stocks To Buy For 2014: International Stem Cell Corp (ISCO)
International Stem Cell Corporation, incorporated on June 7, 2005 is a developmental-stage biotechnology company. The Company focused on therapeutic and biomedical product development. The Company�� wholly owned subsidiary Lifeline Cell Technology, LLC (LCT) develops, manufactures and commercializes over 130 human cell culture products, including frozen human primary cells and the reagents (media) needed to grow, maintain and differentiate the cells, in order to address this market opportunity. The Company�� scientists have used a technology called basal medium optimization to systematically produce optimized products designed to culture specific human cell types and to elicit specific cellular behaviors. The Company�� wholly owned subsidiary Lifeline Skin Care, Inc. (LSC) develops, manufactures and markets cosmetic skin care products using an extract derived from its pluripotent stem cells.
Therapeutic Product Candidates
Using the Company's technologies and know-how, the Company is exploring and creating a range of cell types that is useful in therapeutic treatments, which include Liver cells (hepatocytes) that may be used to treat a range of congenital and acquired liver diseases. Neuronal cells for potential treatment of Parkinson's disease and other central nervous system disorders, such as traumatic brain injury, stroke and Alzheimer�� disease. Three-dimensional eye structures to treat degenerative retinal diseases, corneal blindness, and to accelerate corneal healing.
Skin Care Products
The Company�� research scientists developed two skin care products, Defensive Day Serum and Recovery Night Serum, using an extract derived from human parthenogenic stem cells. Defensive Serum contains sunscreen, along with stem cell-derived ingredients. The day serum not only protects the skin from the aging effects of harsh light, but it continues to nurture the skin�� collagen and fibroblasts to give noticeably firmer, smoother, younger-looking ! skin. The Recovery Night Serum is a nighttime therapy that complements the Defensive Day Serum. The night serum nurtures the skin�� collagen and elastin and contains ingredients to defend against damaging free radicals, to help build firmer, smoother, younger and healthier-looking skin.
Research Products
The Company�� Lifeline subsidiary produces and sells over 250 human cell culture products. These products include frozen human cells and stem cells and the reagents needed to grow, maintain and differentiate the cells. These human cell-based products are used domestically and internationally by research scientists in pharmaceutical, academic and government research organizations to study human disease and basic cell biology.
The Company competes with Genzyme Corporation, StemCell, Advanced Cell Technology Inc., Aastrom Biosciences, ViaCyte, Obagi, SkinCeuticals, SkinMedica, Murad, Lonza, Chemicon, Life Technologies, StemCell Technologies, Merck, BioTime and Specialty Media.
Advisors' Opinion:- [By John Udovich]
Stem cells may not be in the news much�as the sector has moved beyond the use of embryotic�ones, but small cap stem cell stocks Cellular Dynamics International Inc (NASDAQ: ICEL), International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX) have been fairly active over the past several trading days as ICEL went public, ISCO raised additional funding and BRTX grabbed more attention:
- [By John Udovich]
From stem cell burgers to earnings reports, the stem cell industry and small cap players in it like NeoStem Inc (NASDAQ: NBS), International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX) have been producing some news lately that has probably been overlooked by investors and traders alike given its August. Nevertheless, you might want to pay attention to the following stem cell news:
- [By John Udovich]
Summer and the slow news for the market that usually comes with it�is over with and both stem cell researchers or small� cap stem cell stocks like Advanced Cell Technology, Inc (OTCBB: ACTC), Neuralstem, Inc (NYSEMKT: CUR), NeoStem Inc (NASDAQ: NBS), International Stem Cell Corp (OTCMKTS: ISCO)�and BioRestorative Therapies (OTCBB: BRTX) having news for investors and traders alike. Consider the following:
- [By John Udovich]
The results of a recent Pew Center Poll regarding attitudes towards abortion and various forms of stem cell research could be a good sign for the stem cell industry along with small cap stem cell stocks like StemCells Inc (NASDAQ: STEM), NeoStem Inc (NASDAQ: NBS), Neuralstem, Inc (NYSEMKT: CUR),�International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX). Basically, Americans think that having an abortion is a moral issue with 49% of American adults believing abortion is morally wrong, 23%�view it not as a moral issue and and 15% view it as morally acceptable. However and when Americans were asked about issues surrounding�human embryos, such as stem cell research or in vitro fertilization, as a matter of morality, their views were different.
Best Up And Coming Stocks To Buy For 2014: Chino Commercial Bancorp (CCBC)
Chino Commercial Bancorp, incorporated on March 2, 2006, is a bank holding company of Chino Commercial Bank, N.A. (the Bank). The Bank provides a wide variety of lending products for both businesses and consumers. The Bank offers an array of personal, consumer and commercial services generally offered by a locally-managed, independently-operated bank. The Bank provides a range of deposit instruments and general banking services, including checking, savings accounts (including money market demand accounts), certificates of deposit for both business and personal accounts; Internet banking services, such as cash management and Bill Pay; telebanking (banking by phone); and courier services. The Bank operates three full-service banking offices.
Lending Activities
Commercial loan products include lines of credit, letters of credit, term loans, equipment loans, commercial real estate loans, construction loans, accounts receivable financing, working capital financing. Financing products for individuals include auto, home equity, overdraft protection lines and, through a third party provider, MasterCard debit cards. Real estate loan products include construction loans, land loans, mini-perm commercial real estate loans, and home mortgages. As of December 31, 2011, the Company had total assets of $109.7 million and net loans of $55.2 million. Its lending activity is concentrated primarily in real estate loans, which constituted 81.3% of the Company�� loan portfolio as of December 31, 2011, and commercial loans, which constituted 17.6%, of the Company�� loan portfolio as of December 31, 2011.
Investment activities
The Company�� investment security portfolio consists of United States government agency securities, mortgaged-backed securities, municipal bonds and corporate bonds. Investment securities held to maturity are carried at cost, which equates to the unpaid principal balances adjusted for amortization of premium and accretion of discounts.
Sources of funds
Deposits are the Company�� primary source of funds. As of December 31, 2011, the Company�� total deposits were $98.1 million. As of December 31, 2011, its deposits included demand deposits, negotiable order of withdrawal (NOW), savings deposits, money market and time deposits.
Advisors' Opinion:- [By Lisa Levin]
Regional - Pacific Banks: This industry rose 1.54% by 10:40 am ET. The top performer in this industry was Chino Commercial Bancorp (OTC: CCBC), which gained 10.2%. Chino Commercial Bancorp's trailing-twelve-month operating margin is 27.57%.
Best Up And Coming Stocks To Buy For 2014: Pinnacle Financial Partners Inc.(PNFP)
Pinnacle Financial Partners, Inc. operates as the bank holding company for Pinnacle National Bank that provides commercial banking products and services to individuals, small-to medium-sized businesses, and professional entities in Tennessee. It offers various deposit products, including savings, checking, interest-bearing checking, money market, and certificate of deposit accounts. The company also offers commercial loans comprising equipment loans and working capital loans; commercial and residential real estate loans, and construction and development loans; and loans to individuals for personal, family, investment, and household purposes, including secured and unsecured installment and term loans, residential first mortgage loans, home equity loans, and home equity lines of credit. In addition, it provides various investment products, such as mutual funds, variable annuities, money market instruments, the United States treasury securities, bonds, fixed annuities, stocks , financial planning, asset management accounts, and listed options; fiduciary and investment management services for individual and commercial clients, including personal trust, endowments, foundations, individual retirement accounts, pensions, and custody services; investment advisory services; and insurance products primarily in the property and casualty area. Further, the company offers telephone and Internet banking, debit cards, automated teller machines, remote and direct deposit, and cash management services. As of January 17, 2012, it operated 29 offices in 8 Middle Tennessee counties and 3 offices in Knoxville. The company was founded in 2000 and is headquartered in Nashville, Tennessee.
Advisors' Opinion:- [By Monica Gerson]
Pinnacle Financial Partners (NASDAQ: PNFP) is estimated to post its Q3 earnings at $0.42 per share on revenue of $56.99 million.
Commerce Bancshares (NASDAQ: CBSH) is projected to report its Q3 earnings at $0.72 per share on revenue of $254.92 million.
- [By Brian Pacampara]
What: Shares of Pinnacle Financial (NASDAQ: PNFP ) climbed 10% today after the regional bank's quarterly results topped Wall Street expectations.
No comments:
Post a Comment